Nanjing Vazyme Biotech Co., Ltd (SHA:688105)

Nanjing Vazyme Biotech Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 22, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	8,619	8,811	12,808	21,257	42,401	-
Market Cap Growth	-6.04%	-31.21%	-39.74%	-49.87%	-	-
Enterprise Value	6,756	6,995	10,670	18,877	41,383	-
Last Close Price	21.67	22.02	31.61	50.47	100.29	-
PE Ratio	-	-	-	35.77	62.51	-
Forward PE	162.53	43.69	48.03	23.21	57.10	-
PS Ratio	6.41	6.40	9.96	5.96	22.69	-
PB Ratio	2.24	2.23	3.18	4.61	10.27	-
P/TBV Ratio	2.38	2.37	3.37	4.80	10.32	-
P/FCF Ratio	75.51	-	-	-	119.49	-
P/OCF Ratio	55.66	-	83.72	28.91	68.74	-
EV/Sales Ratio	5.03	5.08	8.30	5.29	22.15	-
EV/EBITDA Ratio	-	-	-	20.66	54.37	-
EV/EBIT Ratio	-	-	-	22.20	56.70	-
EV/FCF Ratio	59.19	-	-	-	116.63	-
Debt / Equity Ratio	0.22	0.19	0.32	0.10	0.02	0.00
Debt / EBITDA Ratio	110.58	29.87	-	0.47	0.12	0.00
Debt / FCF Ratio	7.55	-	-	-	0.26	0.00
Asset Turnover	0.27	0.26	0.22	0.67	0.60	1.62
Inventory Turnover	1.15	1.24	1.45	4.59	2.08	1.97
Quick Ratio	3.30	3.50	2.53	3.56	9.76	5.22
Current Ratio	3.73	3.95	2.78	3.96	10.46	5.83
Return on Equity (ROE)	-0.85%	-0.49%	-1.69%	13.58%	24.85%	107.25%
Return on Assets (ROA)	-1.62%	-1.31%	-2.89%	10.02%	14.67%	61.66%
Return on Invested Capital (ROIC)	-6.40%	-5.83%	-14.91%	64.41%	119.81%	357.10%
Return on Capital Employed (ROCE)	-3.20%	-2.70%	-6.40%	17.50%	17.30%	69.60%
Earnings Yield	-0.34%	-0.21%	-0.55%	2.80%	1.60%	-
FCF Yield	1.32%	-0.96%	-0.62%	-1.07%	0.84%	-
Dividend Yield	1.39%	0.82%	0.32%	2.48%	0.30%	-
Payout Ratio	-	-	-	22.25%	0.66%	0.18%
Buyback Yield / Dilution	7.51%	8.20%	1.16%	-9.95%	-1.97%	-
Total Shareholder Return	8.91%	9.02%	1.47%	-7.48%	-1.67%	-

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.